Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating income | -$3.43M | -$1.86M | -$4.60M | -$8.04M | -$9.33M | -$17.6M | -$19.4M |
| Net income | -$3.43M | -$1.86M | -$4.57M | -$7.83M | -$8.89M | -$17.4M | -$19.4M |
| EPS (diluted) | -$1.52 | -$0.20 | -$0.35 | -$0.61 | -$0.69 | -$1.34 | -$1.43 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$293K | -$1.15M | -$4.29M | -$6.20M | -$6.48M | -$7.27M | -$9.91M |
| Share buybacks | — | — | — | $7.54M | — | — | — |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6.83K | $28.7M | $27.2M | $13.5M | $6.99M | $4.09M | $6.18M |
| Total assets | $26.7K | $28.7M | $27.2M | $13.5M | $6.99M | $4.09M | $6.18M |
| Total liabilities | $1.38M | $1.05M | $385K | $263K | $294K | $3.19M | $2.55M |
| Shareholders' equity | -$1.35M | $27.6M | $26.8M | $13.2M | $6.70M | $909K | $353K |
| Retained earnings | -$27.2M | -$29.1M | -$33.6M | -$41.5M | -$50.4M | -$67.8M | -$87.1M |
| Shares (wtd avg diluted) | 8.46M | 12.7M | 13.1M | 12.9M | 12.8M | 13.0M | 13.5M |
Every figure is extracted from Greenwich LifeSciences, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.